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INTRODUCTION
Unlike metastatic cardiac involvement by disseminated
neoplasms, primary tumors of the heart are rare. In a review
of 22 autopsy series, the incidence of such tumors stands at
about 0.02%, with only one-quarter of these cases exhibit-
ing malignant histopathological features (1). Moreover, the
coincidence of pregnancy with one of these primary heart
tumors is an extremely rare occurrence. Only four other cases
of primary cardiac sarcoma (PCS) in pregnancy have been
reported previously in the literature (2-5).
Here, we report a patient presenting at 27+5 weeks gesta-
tion with dyspnea, and diagnosed with a primary cardiac sar-
coma. 
CASE REPORT 
A 29 yr old woman at 27+5 weeks gestation (gravida 1,
para 0) was hospitalized due to dyspnea (NYHA IV) which
had started 10 days before. The patient was healthy in the past,
and the prenatal care findings of the local clinic were non-
specific. According to physical examination, dyspnea was
aggravated at the inspiratory phase and right decubital posi-
tion. Blood pressure was 120/80 mmHg, and her pulse rate
evidenced tarchycardia of 120 beats/min. Both of her neck
veins were engorged. 
Routine blood tests and chest radiography were performed,
but resulted in no peculiarity. Transthoracic echocardiogra-
phy revealed a 5 cm in diameter echogenic mass spreading
from the anterior of the left atrium to the mitral leaflet and
mitral annulus, severe eccentric mitral regurgitation coupled
with severe stenosis, and severe pulmonary hypertension (Fig.
1). The fetus was at a size consistent with IUP 27+2 weeks,
according to obstetric sonography, and appeared to be nor-
mal. The patient was given intramuscular dexamethasone,
5 mg every 12 hr for 4 doses.
The operation on the intracardiac mass was carried out via
median sternotomy. Continuous fetal heart rate and uterine
monitoring were performed using cardiotocography through-
out the procedure. On the area connecting the sternal body
and the xiphoid process, we found a tumor mass about 2 cm
in diameter. A diagnosis by frozen section identified the mass
as sarcoma. We began normothermic cardiopulmonary by-
pass. The mass originating from the atrioventricular wall was
found to have spread all the way to the leaflet and annulus
of the anterior of the mitral valve, so we were compelled to
settle for an incomplete resection of the mass (Fig. 2). We
also performed a mitral valve replacement and a modified
DeVega tricuspid annuloplasty. There was no evidence of
fetal compromise during the operation according to cardio-
tocographic monitoring. 
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Primary Cardiac Sarcoma in Pregnancy 
: A Case Report
Primary cardiac sarcoma is a rare disease in adults. It is also associated with poor
prognoses, due to diagnostic delay, therapeutic difficulty, and high metastatic poten-
tial. The coincidence of pregnancy and a primary cardiac intimal sarcoma is extremely
rare. We report a pregnant woman at 27
+5 weeks gestation who was admitted to the
hospital with acute-onset dyspnea. A mass was found on the left atrium by trans-
thoracic echocardiography. Subsequently, the intracardiac mass was removed, and
mitral valve replacement and modified DeVega tricuspid annuloplasty were performed.
The patient was diagnosed with a undifferentiated sarcoma, and gave birth to a 1,230
g living baby boy by Caesarean section from preterm contraction at 29
+5 weeks ges-
tation. The patient then received systemic chemotherapy. However, 10 months after
the initial clinical onset, the patient suddenly died. Surgery is the standard treatment
for cardiac tumors, and their removal should always be attempted, even in pregnant
women. Although the overall survival rates of the patients are rather poor, palliative
cardiac surgery allows the prolonging of pregnancy, until an acceptable fetal viabili-
ty level is reached.
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Permanent histopathological examination revealed a undif-
ferentiated pleomorphic sarcoma (Fig. 3). The tumor was
immunoreactive for vimentin, but immunohistochemical
stains for cytokeratin, myoglobin, desmin, SMA, S-100 and
CD34 were negative.
After operation, the patient exhibited stable vital signs and
the cardiotocographic monitoring presented nonspecific find-
ings. However, she developed preterm contraction at 29+5
weeks gestation, and we had to deliver a 1,230 g baby by
Caesarean section, whose condition was stable, with Apgar
scores of 5 at 1 min and 7 at 5 min. The operative findings
of both ovaries were nonspecific, and postoperative staging
with whole body computerized tomography was negative.
We, therefore, concluded that the cardiac mass had indeed
Fig. 1. Transthoracic echocardiography shows a mass spreading
from the anterior of the left atrium to the mitral leaflet and mitral an-
nulus.
mass
Fig. 2. The mass originating from the atrioventricular wall was found
to have spread all the way to the anterior leaflet and annulus of the
mitral valve.
MASS
Fig. 3. Photomicrograph of the undifferentiated cardiac intimal sarcoma. (A) The tumor is a highly cellular, showing areas of coagulative
necrosis without any organoid pattern (H&E, ×40). (B) The high power view shows tumor cells with oval to spindle shaped, hyperchromatic
or vesicular nuclei and frequent mitoses (H&E, ×400).
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been primary sarcoma.
The patient then received systemic chemotherapy, with
adriamycin, ifosfamide and darcarbazine. Although the pati-
ent exhibited neutropenia during 3 of the 8 courses of chemo-
therapy, she recovered without any particular complications.
two months after chemotherapy, the patient was again hos-
pitalized for dyspnea and severe abdominal distension. The
results of examinations showed that global function was nor-
mal and the mitral prosthetic valve functioned well on echo-
cardiography. However, computed tomography found a huge
solid mass in the patient’s right pelvic cavity (Fig. 4). After
laparotomy, additional masses were observed. Therefore, we
performed a right oophorectomy for the 30 cm in diameter
right ovarian mass, and an omentectomy for the 20 cm in
diameter omental mass, both of which were diagnosed as
metastatic sarcoma (Fig. 5). ten months after the initial clin-
ical onset, the patient died suddenly. Autopsy was not per-
formed. The infant is presently alive and healthy. 
DISCUSSION 
Primary cardiac tumors are rarely curable by surgery. Com-
plete resection of the tumors is difficult, due to the proximi-
ty to vital structures, and moreover, these tumors are likely
to recur. However, it has been established that surgery, as a
treatment, still has value, in that surgical removal of these
tumors improves hemodynamic cardiac function, thereby
improving the outcome of the patient and, especially when
the tumor can be completely excised, surgery facilitates pro-
longed survival (6). Furthermore, the surgical removal of car-
diac tumors has greater significance when it comes to preg-
nant women. Palliative cardiac surgery allows the prolonging
of pregnancy until suitable fetal viability is reached (2). 
As for adjuvant treatment, the role of adjuvant treatment
in the case of resected PCS remains somewhat controversial,
but it should be a reasonable conclusion that chemotherapy
should be the choice for adjuvant therapy, as local relapse in
PCS is relatively rare, and the common cause of death is not
local relapse but metastatic recurrence. 
Recent improvements in neonatal care have improved sur-
vival of premature infants greater than 28 weeks gestation.
Generally, complete resection is performed as PCS is diag-
nosed, and if there is no evidence of metastasis, the patient
may be closely observed until 28 weeks of gestation. In this
case, complete resection was not performed during the oper-
ation and hence, adjuvant therapy (chemotherapy or radio-
therapy) was considered as gestation corresponded to 28 weeks.
However, Cesarean section was performed due to preterm con-
traction during post-operative care. 
Open-heart operations have been performed at any gesta-
tional age, but are best performed between 24 and 28 weeks
gestation, after the completion of organogenesis, or in the
third trimester if a modern neonatal intensive care unit is
available (7). 
Cardiopulmonary bypass (CPB) was first used during preg-
nancy in 1958. After initial trials, maternal mortality for pre-
gnant patients undergoing CPB became as low as 2.9%. Inter-
estingly, this figure is fairly close to the mortality figures for
non-pregnant patients, although the fetal loss rate in preg-
nant patients undergoing CPB is still reported to be as high
as 20% (8). The standard CPB approach (i.e., hemo-diluted,
Fig. 4. Computed tomography image shows a huge solid mass
with cystic degeneration occupying the pelvic cavity.
Fig. 5. The metastatic ovarian tumor is composed of spindle sha-
ped, malignant cells identical to cardiac tumor (H&E, ×400).Cardiac Tumor in Pregnancy 943
non-pulsatile flow, hypotension, hypothermia) might, how-
ever, prove detrimental in terms of uteroplacental perfusion
and fetal development. The dilution effect of CPB is thought
to reduce hormonal levels (progesterone in particular), which
might augment uterine excitability. Also, experimental evi-
dence suggests that CPB induces a prostaglandin-mediated
increase in placental vascular resistance, which might effect
a reduction in placental blood flow. While a non-pulsatile
flow might be detrimental, pulsatile pressure has its own
merit, as it is believed to attenuate uterine contractions via
the release of endothelium-derived growth factor from the
vascular endothelium (9). Uterine contractions occurring in
the background of decreased perfusion and relative hypoten-
sion associated with CPB may provide inadequate placental
perfusion, causing bradycardia in the fetus as a response. Hy-
pothermia can also induce alterations in acid-base status; lead
to coagulation disorders, arrhythmia, and ventricular fibrilla-
tion; and precipitate uterine contractions, thus reducing pla-
cental oxygen exchange. Embryofetal mortality was 24.0%
when hypothermia was used, compared with 0.0% while oper-
ating under normothermal conditions (8). 
In summary, we present a very unusual coincidence of preg-
nancy and a PCS, in which prompt resection allowed success-
fully the subsequent delivery of a living infant.
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